Skip to content

Author

V. Master

We have 3 of 1,001 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Novel use of computed tomography-derived body composition to facilitate risk assessment in patients with bladder cancer.

BACKGROUND Comprehensive geriatric assessments (CGA) inform risk stratification in bladder cancer (BC) care but are time- and resource-intensive. PURPOSE To investigate whether body composition analysis (BCA) on computed tomography (CT) is associated with CGA. METHODS Patients with BC (any stage) were enrolled in a...

L. Mantz, Alex Zhu, Nathaniel D. Mercaldo et al. · 0 citations
Sep 2026

Risk-dependent Benefit of Adjuvant Pembrolizumab in High-risk Clear Cell Renal Cell Carcinoma: A Multi-institutional Study.

BACKGROUND Adjuvant pembrolizumab improves outcomes in high-risk clear cell renal cell carcinoma (ccRCC), but baseline recurrence risk varies substantially. OBJECTIVE To evaluate treatment selection, outcomes, toxicity, and risk-stratified benefit. DESIGN, SETTING, AND PARTICIPANTS A retrospective cohort of consecu...

D. D. Shapiro, D. Roadman, V. Master et al. · 1 citation
Open access Aug 2026

MSMICA: computational metabolite identification in untargeted metabolomics by integrating MS, retention time, and biological evidence

Mass Spectrometry Metabolomics Identification Connection Algorithm (MSMICA) is an algorithm for automated metabolite identification in untargeted liquid chromatography-high-resolution mass spectrometry (LC-HRMS) analyses. Limitations in metabolite identification can occur due to the availability and cost of standards a...

Jia-Da Zhan, J. Weinberg, William J. Crandall et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.